Related Experiment Video
Updated: Sep 15, 2026
A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
Published on: March 23, 2018
[The effects of cardiopulmonary bypass on pulmonary surfactant activity]
1Department of Cardiothoracic Surgery, Children's Hospital, Shanghai Medical University.
Insights
Cardiopulmonary bypass (CPB) significantly reduces pulmonary surfactant (PS) activity, impacting lung function. This study investigated PS levels in children undergoing CPB for heart conditions.
Area of Science:
- Pulmonary Medicine
- Cardiovascular Surgery
- Biochemistry
Background:
- Pulmonary surfactant (PS) is crucial for maintaining lung function by reducing surface tension.
- Cardiopulmonary bypass (CPB) is a procedure used during heart surgery that can potentially affect lung physiology.
- Understanding the impact of CPB on PS activity is important for optimizing patient outcomes.
Purpose of the Study:
- To investigate the effects of cardiopulmonary bypass (CPB) on pulmonary surfactant (PS) activity.
- To quantify changes in specific PS components before and after CPB in pediatric patients.
Main Methods:
- Airway aspirates were collected from pediatric patients with patent ductus arteriosus (PDA) and ventricular septal defect (VSD) before and after surgery.
- Levels of saturated phosphatidylcholine (SatPC), total phospholipids (TPL), total protein (TP), and surfactant protein-A (SP-A) were measured.
- Sophisticated biochemical assays including chromatography and immunoblotting were employed for precise quantification.
Main Results:
- In patients undergoing CPB for VSD, significant reductions were observed in SatPC/TPL (48% to 34%), SatPC/TP (64 to 33 mg/g), and SP-A (23 to 11 mg/g).
- These reductions in PS components were statistically significant (P < 0.05).
- Patients who did not undergo CPB showed no significant changes in these PS parameters.
Conclusions:
- Cardiopulmonary bypass (CPB) significantly impairs pulmonary surfactant (PS) activity.
- The observed decrease in PS components suggests a potential mechanism for CPB-induced lung dysfunction.
- Further research may explore strategies to mitigate the negative effects of CPB on pulmonary surfactant.
Objective:
To study the effects of cardiopulmonary by pass(CPB) on pulmonary surfactant (PS) activity.
Method:
In 12 children with patent ductus arteriosus(PDA) and 19 patients with ventricular septal defect (VSD), saturated phosphatidylcholine (SatPC), total phospholipids (TPL), total protein (TP) and surfactant protein-A(SP-A) in sequential airway aspirates before and after operation were determined. Tetroxide osmium digestion and neutral alumina column chromatography were used for SatPC, and a modified immunoblot method with a rabbit anti-human SP-A polyclonal antibody for SP-A measurment.
Results:
In 19 VSD patients with CPB, SatPC/TPL was significantly decreased from 48% to 34% (t = 2.737, P < 0.05), SatPC/TP decreased from 64 to 33 mg/g (t = 3.011, P < 0.01), and SP-A from 23 to 11mg/g (t = 2.987, P < 0.01). In 12 patients without CPB, SatPC/TPL, SatPC/TP, SP-A/TP levels were not changed.
Conclusions:
CPB significantly reduces pulmonary surfactant activity.
More Related Videos
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
Published on: April 7, 2021
04:55Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest
Published on: May 26, 2023
